Zhejiang Jingsheng Pharmaceutical is an API manufacturer based in China. It holds 11 active US drug master files and 3 valid CEPs across a filed portfolio of 10 molecules.
| Site | FDA FEI |
|---|---|
| Taizhou, China | Not on file |
| Taizhou City, China | Not on file |
| China, China | 3017488372 |
| Molecule | Regulators | Docs |
|---|---|---|
| Sitagliptin | EDQM, US FDA | 4 |
| Dapagliflozin | US FDA | 2 |
| Empagliflozin | US FDA | 1 |
| Enzalutamide | US FDA | 1 |
| Ezetimibe | US FDA | 1 |
| Finerenone | US FDA | 1 |
| Losartan Potassium | EDQM | 1 |
| Mirogabalin | US FDA | 1 |
| Telmisartan | US FDA | 1 |
| Vonoprazan | US FDA | 1 |
Also appears on these molecule pages
Choose your molecules and target markets. Zhejiang Jingsheng Pharmaceutical comes back tiered against every other supplier able to file there.
Start for free